Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Correction: Transplantation of Adult Mouse iPS Cell-Derived Photoreceptor Precursors Restores Retinal Structure and Function in Degenerative Mice.

Tucker BA, Park IH, Qi SD, Klassen HJ, Jiang C, Yao J, Redenti S, Daley GQ, Young MJ.

PLoS One. 2015 May 7;10(5):e0125947. doi: 10.1371/journal.pone.0125947. eCollection 2015.

2.

Deconstructing transcriptional heterogeneity in pluripotent stem cells.

Kumar RM, Cahan P, Shalek AK, Satija R, DaleyKeyser AJ, Li H, Zhang J, Pardee K, Gennert D, Trombetta JJ, Ferrante TC, Regev A, Daley GQ, Collins JJ.

Nature. 2014 Dec 4;516(7529):56-61. doi: 10.1038/nature13920.

3.

A comparison of non-integrating reprogramming methods.

Schlaeger TM, Daheron L, Brickler TR, Entwisle S, Chan K, Cianci A, DeVine A, Ettenger A, Fitzgerald K, Godfrey M, Gupta D, McPherson J, Malwadkar P, Gupta M, Bell B, Doi A, Jung N, Li X, Lynes MS, Brookes E, Cherry AB, Demirbas D, Tsankov AM, Zon LI, Rubin LL, Feinberg AP, Meissner A, Cowan CA, Daley GQ.

Nat Biotechnol. 2015 Jan;33(1):58-63. doi: 10.1038/nbt.3070. Epub 2014 Dec 1.

4.

A nontranscriptional role for Oct4 in the regulation of mitotic entry.

Zhao R, Deibler RW, Lerou PH, Ballabeni A, Heffner GC, Cahan P, Unternaehrer JJ, Kirschner MW, Daley GQ.

Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15768-73. doi: 10.1073/pnas.1417518111. Epub 2014 Oct 16.

5.

The epithelial-mesenchymal transition factor SNAIL paradoxically enhances reprogramming.

Unternaehrer JJ, Zhao R, Kim K, Cesana M, Powers JT, Ratanasirintrawoot S, Onder T, Shibue T, Weinberg RA, Daley GQ.

Stem Cell Reports. 2014 Nov 11;3(5):691-8. doi: 10.1016/j.stemcr.2014.09.008. Epub 2014 Oct 11.

6.

Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.

Fox IJ, Daley GQ, Goldman SA, Huard J, Kamp TJ, Trucco M.

Science. 2014 Aug 22;345(6199):1247391. doi: 10.1126/science.1247391. Review.

7.

Effect of developmental stage of HSC and recipient on transplant outcomes.

Arora N, Wenzel PL, McKinney-Freeman SL, Ross SJ, Kim PG, Chou SS, Yoshimoto M, Yoder MC, Daley GQ.

Dev Cell. 2014 Jun 9;29(5):621-8. doi: 10.1016/j.devcel.2014.04.013.

8.

Functional evaluation of ES-somatic cell hybrids in vitro and in vivo.

Sumer H, Kim K, Liu J, Ng K, Daley GQ, Verma PJ.

Cell Reprogram. 2014 Jun;16(3):167-74. doi: 10.1089/cell.2013.0079. Epub 2014 May 2.

9.

Lin28 sustains early renal progenitors and induces Wilms tumor.

Urbach A, Yermalovich A, Zhang J, Spina CS, Zhu H, Perez-Atayde AR, Shukrun R, Charlton J, Sebire N, Mifsud W, Dekel B, Pritchard-Jones K, Daley GQ.

Genes Dev. 2014 May 1;28(9):971-82. doi: 10.1101/gad.237149.113. Epub 2014 Apr 14.

10.

Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs.

Park SM, Deering RP, Lu Y, Tivnan P, Lianoglou S, Al-Shahrour F, Ebert BL, Hacohen N, Leslie C, Daley GQ, Lengner CJ, Kharas MG.

J Exp Med. 2014 Jan 13;211(1):71-87. doi: 10.1084/jem.20130736. Epub 2014 Jan 6.

11.

Lin28 enhances tissue repair by reprogramming cellular metabolism.

Shyh-Chang N, Zhu H, Yvanka de Soysa T, Shinoda G, Seligson MT, Tsanov KM, Nguyen L, Asara JM, Cantley LC, Daley GQ.

Cell. 2013 Nov 7;155(4):778-92. doi: 10.1016/j.cell.2013.09.059.

12.

Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.

Fuchs NV, Loewer S, Daley GQ, Izsvák Z, Löwer J, Löwer R.

Retrovirology. 2013 Oct 24;10:115. doi: 10.1186/1742-4690-10-115.

13.

Proteolytic autodigestion: common tissue pathology in Shwachman-Diamond syndrome?

Kelley JM, Tulpule A, Daley GQ.

Cell Cycle. 2013;12(22):3457-8. doi: 10.4161/cc.26698. Epub 2013 Oct 8. No abstract available.

14.

Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors.

Doulatov S, Vo LT, Chou SS, Kim PG, Arora N, Li H, Hadland BK, Bernstein ID, Collins JJ, Zon LI, Daley GQ.

Cell Stem Cell. 2013 Oct 3;13(4):459-70. doi: 10.1016/j.stem.2013.09.002.

15.

Hematopoietic defects and iPSC disease modeling: lessons learned.

Kelley JM, Daley GQ.

Immunol Lett. 2013 Sep-Oct;155(1-2):18-20. doi: 10.1016/j.imlet.2013.09.018. Epub 2013 Sep 25.

16.

A chemical logic for reprogramming to pluripotency.

De Los Angeles A, Daley GQ.

Cell Res. 2013 Dec;23(12):1337-8. doi: 10.1038/cr.2013.119. Epub 2013 Aug 27.

17.

Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".

Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park IH, Friedman BA, Daley GQ, Wyllie DJ, Hardingham GE, Wilmut I, Finkbeiner S, Maniatis T, Shaw CE, Chandran S.

Sci Transl Med. 2013 Jun 5;5(188):188le2. doi: 10.1126/scitranslmed.3005065.

18.

Stem cell metabolism in tissue development and aging.

Shyh-Chang N, Daley GQ, Cantley LC.

Development. 2013 Jun;140(12):2535-47. doi: 10.1242/dev.091777. Review.

19.

Origins and implications of pluripotent stem cell variability and heterogeneity.

Cahan P, Daley GQ.

Nat Rev Mol Cell Biol. 2013 Jun;14(6):357-68. doi: 10.1038/nrm3584. Epub 2013 May 15. Review.

20.

Fetal deficiency of lin28 programs life-long aberrations in growth and glucose metabolism.

Shinoda G, Shyh-Chang N, Soysa TY, Zhu H, Seligson MT, Shah SP, Abo-Sido N, Yabuuchi A, Hagan JP, Gregory RI, Asara JM, Cantley LC, Moss EG, Daley GQ.

Stem Cells. 2013 Aug;31(8):1563-73. doi: 10.1002/stem.1423.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk